25/03/2014
1
What can we learn from the gene7c code of TB?
Timothy Walker
conditions and reduce inequity (Chisholm,1948; Rosen,1974). Afterthe second World War, a medically oriented TB control modelemerged (Amrith, 2002). Much hope was initially placed on massvaccination with BCG (Brimnes, 2007), hopes which were latershattered when it was demonstrated that the protective effect andepidemiological impact were limited (Rieder, 1999). When effectivechemotherapy for TB became available in the end of the 1940 andbeginning of 1950s, the control model switched to an almostcompletely curative focus. ‘‘Prevention starts with cure’’ becamea slogan for the global role out of effective treatments. It was pre-dicted that good coverage of effective treatment would result ina rapid decline in TB incidence (Styblo & Bumgarner, 1991).However, some recent observations have indicated that the impactof the present TB control strategy has been less than expected(WHO, 2008a). If these observations are confirmed, there may bea need to again broaden the strategy to include more preventiveefforts (Farmer, 1997; Jaramillo, 1999). One avenue for improved TBprevention is the ongoing quest for better TB vaccines and betterchemotherapy for preventive treatment. Another avenue leadsthrough actions to address the social determinants of TB, as well asthe more proximate risk factors (the physical and biomedicalfactors that directly influence the mechanisms that govern expo-sure to tuberculosis, risk of acquiring tuberculosis infection, andrisk of progression from tuberculosis infection to active tubercu-losis disease).
In order to assess the relevance and potential benefits of thelatter, a review was conducted to identify key social determinantsof TB and the possible causal pathways throughwhich they operate.We also reviewed the historical and recent progress in global TBcontrol with a view to assess the prospects of effectively controllingTB in the future with the current global strategy, and the potentialto increase epidemiological impact through adding actions onsocial determinants and risk factors.
Methods
A literature review was undertaken to identify historic andrecent trends in TB burden; social determinants of TB; and themostimportant proximate TB risk factors. We searched PubMed, thesend-list ‘‘TB-Related News and Journal Items Weekly Update’’(Centre for Disease Control and Prevention, Atlanta, USA), anda private data-base on tuberculosis publications from the past 40years (created by Dr Hans Rieder). The analysis was carried out bythe Stop TB Department at WHO, in collaboration with other rele-vant WHO Departments, including those responsible for tobaccocontrol, nutrition, alcohol and substance abuse, environmentalhealth, diabetes, and HIV/AIDS. The Priority Public Health ConditionKnowledge Network of the CSDH provided technical support andfeedback.
Findings
History of TB epidemiology and social change in industrializedcountries
Epidemiological TB data before the 20th century is imprecise.However, some broad trends have been identified with a reason-able level of certainty. The conventional wisdom is that the inci-dence of TB increased in industrialized countries in the 17th to 18thcenturies, peaking at different times in different places from themiddle of the 1700s in Great Britain to the beginning of the 1900s inJapan. From these trends, a temporal association has been sug-gested between increased TB incidence and rapid industrializationand urbanisation. TB rates were often particularly high in urbanareas. A plausible explanation is that transmission increased due to
increased population density and crowded living conditions, whilepoor nutritional status and other risk factors increased the risk ofbreak-down from infection to active disease in vulnerable groups,such as among the urban poor (Aparicio, Capurro, & Castillo-Chavez, 2002; Grundy, 2005; Rieder, 1999; Shimao, 2005). At thepeak of the epidemic in Europe TB death rates were close to 1% peryear in some urban areas, several times higher than the currentrates in countries with high HIV prevalence (Fig. 1).
Throughout the 20th century, even before the introduction ofeffective chemotherapy, TB incidence declined steadily in mostindustrialized countries although it did increase temporarily duringthe twoWorldWars (Fig. 2). This was a period of economic growth,social reform, poverty reduction and improved living conditions aswell as important advances in medicine and public health. Therelative importance of the factors that may have contributed to thedecline in TB in the 20th century is still a matter of debate.McKeown and Record (1962) suggested that before the 1950s thedecline was due to improved nutritional status and to some extentimproved living conditions, while medical and public healthinterventions had only a marginal impact before chemotherapybecame available. Others have convincingly argued that the intro-duction of sanatoria and other mechanisms to isolate infectiouscases as well as pasteurization of milk also had a significant impacton trends in the incidence of TB (Fairchild & Oppenheimer, 1998;Grundy, 2005; Lienhardt, 2001; Wilson, 2005). Natural selectionmay also have played a role (Davies, Tocque, Bellis, Rimmington, &Davies, 1999).
The discovery of the TB bacillus in 1882 was an outstandingadvance in the understanding of transmissible diseases, andmarked the beginning of the germ theory era. As a result of thisdiscovery, a TB control paradigm based mostly on the biologicalunderstanding of the disease gradually emerged. It received a finalboost with the discovery in the 1940s and 1950s of drugs that couldcure the disease (Amrith, 2002). The expanded pharmacopeia ofanti-TB drugs in the 1950s and 1960s helped to sustain and perhapsaccelerate the decline in TB incidence (Fig. 2). But this was not onlya period of rapid medical and health care advances. It was alsoa time of both rapid economic growth and accelerated welfarereforms in many industrialized countries (Navarro et al., 2006).Progress in TB control in the industrialized countries over the pastcenturies was thus brought about by advances on several fronts atthe same time – medical, public health, economic and social.
The evolution of the WHO’s TB control strategy
After decades of TB control neglect, with sustained high TBburden in many low- and middle income countries and a resur-gence of TB in several high-income countries in the 1980s, global
Fig. 1. Modelled tuberculosis deaths rates or selected European cities 1750–1950(source: Rieder, 1999).
K. Lonnroth et al. / Social Science & Medicine 68 (2009) 2240–2246 2241
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
Knut Lonnroth*, Ernesto Jaramillo, Brian G. Williams, Christopher Dye, Mario RaviglioneWorld Health Organization, Geneva, Switzerland
a r t i c l e i n f o
Article history:Available online 23 April 2009
Keywords:TuberculosisDisease controlSocial determinantsRisk factorsReviewEpidemiologyWHO
a b s t r a c t
The main thrust of the World Health Organization’s global tuberculosis (TB) control strategy is to ensureeffective and equitable delivery of quality assured diagnosis and treatment of TB. Options for includingpreventive efforts have not yet been fully considered. This paper presents a narrative review of thehistorical and recent progress in TB control and the role of TB risk factors and social determinants. Thereview was conducted with a view to assess the prospects of effectively controlling TB under the currentstrategy, and the potential to increase epidemiological impact through additional preventive interven-tions. The review suggests that, while the current strategy is effective in curing patients and saving lives,the epidemiological impact has so far been less than predicted. In order to reach long-term epidemio-logical targets for global TB control, additional interventions to reduce peoples’ vulnerability for TB maytherefore be required. Risk factors that seem to be of importance at the population level include poorliving and working conditions associated with high risk of TB transmission, and factors that impair thehost’s defence against TB infection and disease, such as HIV infection, malnutrition, smoking, diabetes,alcohol abuse, and indoor air pollution. Preventive interventions may target these factors directly or viatheir underlying social determinants. The identification of risk groups also helps to target strategies forearly detection of people in need of TB treatment. More research is needed on the suitability, feasibilityand cost-effectiveness of these intervention options.
! 2009 Elsevier Ltd. All rights reserved.
Introduction
The Commission on Social Determinants for Health (CSDH), setup by the World Health Organization (WHO) in 2005, hasattempted to revitalize the debate and actions to improve healththrough addressing the ‘‘causes of the causes’’ of ill health. Thecommission has developed action frameworks in several fields toaddress the social determinants of health including early childhooddevelopment, globalization, urbanisation, employment conditions,social exclusion, etc. A key message from the CSDH is that publichealth achievements will largely depend on actions outside thehealth care sector (CSDH, 2008).
The work of the commission builds on a long social medicinetradition, from Virchow and the public health oriented social andenvironmental interventions that he and others inspired from themid-19th century onwards (Rosen, 1974), through the social modelof health adopted byWHO in the late 1940s (Chisholm,1948), to theHealth for All concept in the 1970s (WHO, 1978). It has not alwaysbeen easy to keep the social medicine concepts and action
frameworks alive (Amrith, 2002; Rosen, 1974). Several countrieshave tried consistently to pursue social policies aimed to promoteequity in health, some with a great deal of success (CSDH, 2008).However, in most countries, little of the social model of healthadvocated by WHO and others was translated into practice. Asa consequence, much preventable ill health and health inequityprevails today (CSDH, 2008).
The last 2–3 decades have seen reinvigorated attempts to fightdiseases with medical technologies alone. Key concepts in today’sdiscourse on disease control include: evidence-based medicine;health systems strengthening; and community involvement. Thelatter two focuses mainly on the capacity to deliver medical tech-nologies effectively. Meanwhile, social medicine has often beenreduced to actions to identify risk groups that need to be targetedwith medical interventions and attempts to influence individuals’risk behaviour (Porter, 2006).
The current global tuberculosis (TB) control paradigm mainlyfocuses on cutting transmission through early case detection andeffective treatment. Medical interventions are at the core of theglobal strategy (Lonnroth & Raviglione, 2008; WHO, 2006).However, historically, TB has been used as a prime example ofa ‘‘social disease’’, the control of which requires social, economicand environmental interventions. Furthermore, the need to controlTB has often been used as an argument for improving living
* Corresponding author. World Health Organization, Stop TB Department, 20Avenue Appia, CH-1211 Geneva, Switzerland. Tel.: þ41 22 7911628, fax: þ41 227914199.
E-mail address: [email protected] (K. Lonnroth).
Contents lists available at ScienceDirect
Social Science & Medicine
journal homepage: www.elsevier .com/locate/socscimed
0277-9536/$ – see front matter ! 2009 Elsevier Ltd. All rights reserved.doi:10.1016/j.socscimed.2009.03.041
Social Science & Medicine 68 (2009) 2240–2246
25/03/2014
2
9.4 million new cases of TB globally in 2009 80% of these in just 22 countries
25/03/2014
3
The problem with the current workflow
25/03/2014
4
25/03/2014
5
25/03/2014
6
✗
25/03/2014
7
✗ ✗ ✗ ✗ ✗ ✗
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
25/03/2014
8
Clinical specimen referred to look for mycobacteria
Auramine microscopy performed
BACTEC MGIT nega7ve
HAIN line probe assay to iden7fy
species
Cepheid Gene Xpert + LPA
Solid based phenotypic sensi7vity tes7ng for the 4 first line drugs
All sensi7ve
Issue report
One or more resistant
HAIN MTBDRplus
2nd line MGIT DST & HAIN MTBDRsl
Mtb /MTBC
NTM
Phenotypic sensi7vity tes7ng if appropriate
Issue preliminary report
MIRU-‐VNTR typing -‐24 VNTR
Issue report
Issue report
Resistant
ZN performed to direct towards NTM or MTBC HAIN strip for species iden7fica7on
Issue report
Sensi7ve
Clinician Lab Requests
Issue Report
LJ + BACTEC MGIT inoculated
BACTEC MGIT Posi7ve
Tissue Block
LPA
Issue Report Hain MDRTB test (confirm Rif R and INH R)
Culture subbed to LJ slope in NMRL
16s RNA Sequencing as needed
Extended Sensi7vity Clarithromycin for rapid growers
Issue report
Addi7onal Loci as needed
Issue report
Liquid DST for first line, second line and reserve drugs if RIF Resistant
The M. tuberculosis genome -‐ Circular genome -‐ 4.4 million base pairs long -‐ 4000 genes -‐ Evolves by descent (no
horizontal gene transfer)
25/03/2014
9
Future vision and direc/on In one step generate the complete diagnos/c,
typing and surveillance informa/on
transmission
virulence
spec
ies
iden
tifi
cati
on
resistance
Microbiology COMPASS: COMplete PAthogen Sequencing Solution
Articles
www.thelancet.com/infection Published online November 15, 2012 http://dx.doi.org/10.1016/S1473-3099(12)70277-3 5
within the variation we recorded, some rates were con-sistent with latent infection. All longitudinally sampled patients received antituberculosis drug treatment. HIV testing was not systematically done until 2011 (only eight results were available, all negative); however, UK rates of co-infection are fairly low, declining steadily from 9·0% in 2003, to 4·9% in 2010.28 We recorded weak evidence that the initial genetic diversity and rate of change in DNA sequences might vary be tween household outbreaks and longitudinally sampled individuals (joint vs separate models, p=0·08). However, the mu tation rate was lower in individuals followed up longitudinally (0·3 SNPs per genome per year [95% CI 0–0·6]) than in those in household outbreaks (0·6 SNPs per genome per year [0·3–0·9]), and the initial diversity was higher (1·2 SNPs [0·3–1·9] vs 0·2 SNPs [0·008–0·7]).
We used these results to construct two thresholds against which to assess the MIRU-VNTR-based community clusters. We expected epidemiological link-age consistent with transmission to exist between isolates diff ering by fi ve or fewer SNPs, and not to exist between isolates diff ering by more than 12 SNPs. We deemed pairs diff ering by six to 12 SNPs to be indeterminate.
The 11 community clusters were defi ned by their MIRU-VNTR profi le (or up to two locus mismatches; table). Starting from the fi rst case in each cluster, we constructed 11 networks (one for each cluster), accounting for 157 potential transmissions (edges; appendix). Within the three clusters centred on schools, 17 (85%) of 20 patients
could be epidemiologically linked (table), with no link confi rmed in three MIRU-VNTR-matched community isolates (the community-based case in cluster three was 35 SNPs away from the school isolates). In clusters six and seven, 27 (79%) of 34 patients could also be
0123456789
101112
13–30
31–150
>400
SNPs
Cross-sectionalisolates
(49 patients)
Longitudinalisolates
(30 patients)†
Householdisolates
(38 links)
Knownlinkage
(47)
Possiblelinkage
(13)
No knownlinkage
(75)
0 20 40 60 80 100 120Months
SNPs
0
2
4
6
8
10
Minimum diversitywithin households
Maximum diversitywithin individuals
Minimum diversity between patients inMIRU-VTNR community clusters
A BIndividualsHouseholdsStepwise 95% prediction intervalMean rate of change95% CI
*
Figure 2: Genetic diversity of related isolates of Mycobacterium tuberculosis(A) Time-unadjusted pairwise genetic distances in SNPs. 22 of the 38 links within the 25 household clusters also occur within community clusters (ie, known linkage) but are shown with household isolates and not with community isolates. Top horizontal dashed line indicates the threshold above which direct transmission can be judged to be unlikely; bottom horizontal dashed line indicates the threshold below which transmission should be investigated. (B) Rate of change in DNA sequences estimated by coalescent-based maximum likelihood from the fi rst and last isolates from individuals with persistent open tuberculosis and from households. SNP=single nucleotide polymorphism. MIRU-VNTR=mycobacterial interspersed repetitive-unit–variable-number tandem-repeat.*Isolates had substantially diff erent MIRU-VNTR profi les. †Pair of Mycobacterium africanum isolates are represented two SNPs apart.
0
1
23457
8–1213–2021–3031–4041–5051–70
71–100
101–200201–300301–400401–500501–700
701–1000
1001–2000
SNPs
0 2 4 6 8 10 12 14 16 18 20 22MIRU–VNTR loci
Figure 3: SNPs between MIRU-VNTR types by number of locus diff erencesComparison of all isolates with complete 24-locus MIRU-VNTR profi les. As each isolate was compared to each other isolate, the number of SNPs and MIRU-VNTR loci at which they diverge was recorded. Results are plotted on a log scale. Circle sizes are proportionate to the number of pairs diverging by a specifi c number of loci and SNPs. Dashed red box includes isolates that diff er by fi ve or fewer SNPs. SNP=single nucleotide polymorphism. MIRU-VNTR=mycobacterial interspersed repetitive-unit–variable-number tandem-repeat.
25/03/2014
10
Articles
www.thelancet.com/infection Published online November 15, 2012 http://dx.doi.org/10.1016/S1473-3099(12)70277-3 5
within the variation we recorded, some rates were con-sistent with latent infection. All longitudinally sampled patients received antituberculosis drug treatment. HIV testing was not systematically done until 2011 (only eight results were available, all negative); however, UK rates of co-infection are fairly low, declining steadily from 9·0% in 2003, to 4·9% in 2010.28 We recorded weak evidence that the initial genetic diversity and rate of change in DNA sequences might vary be tween household outbreaks and longitudinally sampled individuals (joint vs separate models, p=0·08). However, the mu tation rate was lower in individuals followed up longitudinally (0·3 SNPs per genome per year [95% CI 0–0·6]) than in those in household outbreaks (0·6 SNPs per genome per year [0·3–0·9]), and the initial diversity was higher (1·2 SNPs [0·3–1·9] vs 0·2 SNPs [0·008–0·7]).
We used these results to construct two thresholds against which to assess the MIRU-VNTR-based community clusters. We expected epidemiological link-age consistent with transmission to exist between isolates diff ering by fi ve or fewer SNPs, and not to exist between isolates diff ering by more than 12 SNPs. We deemed pairs diff ering by six to 12 SNPs to be indeterminate.
The 11 community clusters were defi ned by their MIRU-VNTR profi le (or up to two locus mismatches; table). Starting from the fi rst case in each cluster, we constructed 11 networks (one for each cluster), accounting for 157 potential transmissions (edges; appendix). Within the three clusters centred on schools, 17 (85%) of 20 patients
could be epidemiologically linked (table), with no link confi rmed in three MIRU-VNTR-matched community isolates (the community-based case in cluster three was 35 SNPs away from the school isolates). In clusters six and seven, 27 (79%) of 34 patients could also be
0123456789
101112
13–30
31–150
>400
SNPs
Cross-sectionalisolates
(49 patients)
Longitudinalisolates
(30 patients)†
Householdisolates
(38 links)
Knownlinkage
(47)
Possiblelinkage
(13)
No knownlinkage
(75)
0 20 40 60 80 100 120Months
SNPs
0
2
4
6
8
10
Minimum diversitywithin households
Maximum diversitywithin individuals
Minimum diversity between patients inMIRU-VTNR community clusters
A BIndividualsHouseholdsStepwise 95% prediction intervalMean rate of change95% CI
*
Figure 2: Genetic diversity of related isolates of Mycobacterium tuberculosis(A) Time-unadjusted pairwise genetic distances in SNPs. 22 of the 38 links within the 25 household clusters also occur within community clusters (ie, known linkage) but are shown with household isolates and not with community isolates. Top horizontal dashed line indicates the threshold above which direct transmission can be judged to be unlikely; bottom horizontal dashed line indicates the threshold below which transmission should be investigated. (B) Rate of change in DNA sequences estimated by coalescent-based maximum likelihood from the fi rst and last isolates from individuals with persistent open tuberculosis and from households. SNP=single nucleotide polymorphism. MIRU-VNTR=mycobacterial interspersed repetitive-unit–variable-number tandem-repeat.*Isolates had substantially diff erent MIRU-VNTR profi les. †Pair of Mycobacterium africanum isolates are represented two SNPs apart.
0
1
23457
8–1213–2021–3031–4041–5051–70
71–100
101–200201–300301–400401–500501–700
701–1000
1001–2000
SNPs
0 2 4 6 8 10 12 14 16 18 20 22MIRU–VNTR loci
Figure 3: SNPs between MIRU-VNTR types by number of locus diff erencesComparison of all isolates with complete 24-locus MIRU-VNTR profi les. As each isolate was compared to each other isolate, the number of SNPs and MIRU-VNTR loci at which they diverge was recorded. Results are plotted on a log scale. Circle sizes are proportionate to the number of pairs diverging by a specifi c number of loci and SNPs. Dashed red box includes isolates that diff er by fi ve or fewer SNPs. SNP=single nucleotide polymorphism. MIRU-VNTR=mycobacterial interspersed repetitive-unit–variable-number tandem-repeat.
Articles
www.thelancet.com/infection Published online November 15, 2012 http://dx.doi.org/10.1016/S1473-3099(12)70277-3 5
within the variation we recorded, some rates were con-sistent with latent infection. All longitudinally sampled patients received antituberculosis drug treatment. HIV testing was not systematically done until 2011 (only eight results were available, all negative); however, UK rates of co-infection are fairly low, declining steadily from 9·0% in 2003, to 4·9% in 2010.28 We recorded weak evidence that the initial genetic diversity and rate of change in DNA sequences might vary be tween household outbreaks and longitudinally sampled individuals (joint vs separate models, p=0·08). However, the mu tation rate was lower in individuals followed up longitudinally (0·3 SNPs per genome per year [95% CI 0–0·6]) than in those in household outbreaks (0·6 SNPs per genome per year [0·3–0·9]), and the initial diversity was higher (1·2 SNPs [0·3–1·9] vs 0·2 SNPs [0·008–0·7]).
We used these results to construct two thresholds against which to assess the MIRU-VNTR-based community clusters. We expected epidemiological link-age consistent with transmission to exist between isolates diff ering by fi ve or fewer SNPs, and not to exist between isolates diff ering by more than 12 SNPs. We deemed pairs diff ering by six to 12 SNPs to be indeterminate.
The 11 community clusters were defi ned by their MIRU-VNTR profi le (or up to two locus mismatches; table). Starting from the fi rst case in each cluster, we constructed 11 networks (one for each cluster), accounting for 157 potential transmissions (edges; appendix). Within the three clusters centred on schools, 17 (85%) of 20 patients
could be epidemiologically linked (table), with no link confi rmed in three MIRU-VNTR-matched community isolates (the community-based case in cluster three was 35 SNPs away from the school isolates). In clusters six and seven, 27 (79%) of 34 patients could also be
0123456789
101112
13–30
31–150
>400
SNPs
Cross-sectionalisolates
(49 patients)
Longitudinalisolates
(30 patients)†
Householdisolates
(38 links)
Knownlinkage
(47)
Possiblelinkage
(13)
No knownlinkage
(75)
0 20 40 60 80 100 120Months
SNPs
0
2
4
6
8
10
Minimum diversitywithin households
Maximum diversitywithin individuals
Minimum diversity between patients inMIRU-VTNR community clusters
A BIndividualsHouseholdsStepwise 95% prediction intervalMean rate of change95% CI
*
Figure 2: Genetic diversity of related isolates of Mycobacterium tuberculosis(A) Time-unadjusted pairwise genetic distances in SNPs. 22 of the 38 links within the 25 household clusters also occur within community clusters (ie, known linkage) but are shown with household isolates and not with community isolates. Top horizontal dashed line indicates the threshold above which direct transmission can be judged to be unlikely; bottom horizontal dashed line indicates the threshold below which transmission should be investigated. (B) Rate of change in DNA sequences estimated by coalescent-based maximum likelihood from the fi rst and last isolates from individuals with persistent open tuberculosis and from households. SNP=single nucleotide polymorphism. MIRU-VNTR=mycobacterial interspersed repetitive-unit–variable-number tandem-repeat.*Isolates had substantially diff erent MIRU-VNTR profi les. †Pair of Mycobacterium africanum isolates are represented two SNPs apart.
0
1
23457
8–1213–2021–3031–4041–5051–70
71–100
101–200201–300301–400401–500501–700
701–1000
1001–2000
SNPs
0 2 4 6 8 10 12 14 16 18 20 22MIRU–VNTR loci
Figure 3: SNPs between MIRU-VNTR types by number of locus diff erencesComparison of all isolates with complete 24-locus MIRU-VNTR profi les. As each isolate was compared to each other isolate, the number of SNPs and MIRU-VNTR loci at which they diverge was recorded. Results are plotted on a log scale. Circle sizes are proportionate to the number of pairs diverging by a specifi c number of loci and SNPs. Dashed red box includes isolates that diff er by fi ve or fewer SNPs. SNP=single nucleotide polymorphism. MIRU-VNTR=mycobacterial interspersed repetitive-unit–variable-number tandem-repeat.
25/03/2014
11
Articles
www.thelancet.com/infection Published online November 15, 2012 http://dx.doi.org/10.1016/S1473-3099(12)70277-3 5
within the variation we recorded, some rates were con-sistent with latent infection. All longitudinally sampled patients received antituberculosis drug treatment. HIV testing was not systematically done until 2011 (only eight results were available, all negative); however, UK rates of co-infection are fairly low, declining steadily from 9·0% in 2003, to 4·9% in 2010.28 We recorded weak evidence that the initial genetic diversity and rate of change in DNA sequences might vary be tween household outbreaks and longitudinally sampled individuals (joint vs separate models, p=0·08). However, the mu tation rate was lower in individuals followed up longitudinally (0·3 SNPs per genome per year [95% CI 0–0·6]) than in those in household outbreaks (0·6 SNPs per genome per year [0·3–0·9]), and the initial diversity was higher (1·2 SNPs [0·3–1·9] vs 0·2 SNPs [0·008–0·7]).
We used these results to construct two thresholds against which to assess the MIRU-VNTR-based community clusters. We expected epidemiological link-age consistent with transmission to exist between isolates diff ering by fi ve or fewer SNPs, and not to exist between isolates diff ering by more than 12 SNPs. We deemed pairs diff ering by six to 12 SNPs to be indeterminate.
The 11 community clusters were defi ned by their MIRU-VNTR profi le (or up to two locus mismatches; table). Starting from the fi rst case in each cluster, we constructed 11 networks (one for each cluster), accounting for 157 potential transmissions (edges; appendix). Within the three clusters centred on schools, 17 (85%) of 20 patients
could be epidemiologically linked (table), with no link confi rmed in three MIRU-VNTR-matched community isolates (the community-based case in cluster three was 35 SNPs away from the school isolates). In clusters six and seven, 27 (79%) of 34 patients could also be
0123456789
101112
13–30
31–150
>400
SNPs
Cross-sectionalisolates
(49 patients)
Longitudinalisolates
(30 patients)†
Householdisolates
(38 links)
Knownlinkage
(47)
Possiblelinkage
(13)
No knownlinkage
(75)
0 20 40 60 80 100 120Months
SNPs
0
2
4
6
8
10
Minimum diversitywithin households
Maximum diversitywithin individuals
Minimum diversity between patients inMIRU-VTNR community clusters
A BIndividualsHouseholdsStepwise 95% prediction intervalMean rate of change95% CI
*
Figure 2: Genetic diversity of related isolates of Mycobacterium tuberculosis(A) Time-unadjusted pairwise genetic distances in SNPs. 22 of the 38 links within the 25 household clusters also occur within community clusters (ie, known linkage) but are shown with household isolates and not with community isolates. Top horizontal dashed line indicates the threshold above which direct transmission can be judged to be unlikely; bottom horizontal dashed line indicates the threshold below which transmission should be investigated. (B) Rate of change in DNA sequences estimated by coalescent-based maximum likelihood from the fi rst and last isolates from individuals with persistent open tuberculosis and from households. SNP=single nucleotide polymorphism. MIRU-VNTR=mycobacterial interspersed repetitive-unit–variable-number tandem-repeat.*Isolates had substantially diff erent MIRU-VNTR profi les. †Pair of Mycobacterium africanum isolates are represented two SNPs apart.
0
1
23457
8–1213–2021–3031–4041–5051–70
71–100
101–200201–300301–400401–500501–700
701–1000
1001–2000
SNPs
0 2 4 6 8 10 12 14 16 18 20 22MIRU–VNTR loci
Figure 3: SNPs between MIRU-VNTR types by number of locus diff erencesComparison of all isolates with complete 24-locus MIRU-VNTR profi les. As each isolate was compared to each other isolate, the number of SNPs and MIRU-VNTR loci at which they diverge was recorded. Results are plotted on a log scale. Circle sizes are proportionate to the number of pairs diverging by a specifi c number of loci and SNPs. Dashed red box includes isolates that diff er by fi ve or fewer SNPs. SNP=single nucleotide polymorphism. MIRU-VNTR=mycobacterial interspersed repetitive-unit–variable-number tandem-repeat.
OX4
OX3
OX16
0.00 - 4.99
5.00 - 9.99
10.00 - 14.99
15.00 - 19.99
20.00 - 24.99
25.00 - 29.99
30.00 - 34.99
Tuberculosis rates (per 100,000 population)Oxfordshire (2007-2012)
Map produced using PHEGIS. Contact GIS Team, ERD/MRA, Porton Down. 01980-616937 or [email protected]
© Crown copyright and database rights 2013 Ordnance Survey 100016969.4Born in a high-‐incidence country: 109/100000 popula7on
Born in a low-‐incidence country: 3.5/100000 popula7on
25/03/2014
12
Source:
020
4060
8010
0N
umbe
r of
Pat
ient
s
UN
ITE
D K
ING
DO
MIN
DIA
PA
KIS
TAN
TIM
OR
-LE
ST
EP
HIL
IPP
INE
SB
AN
GLA
DE
SH
NIG
ER
IAK
EN
YA
NE
PA
LS
OM
ALI
AS
OU
TH
AF
RIC
AC
HIN
AA
FG
HA
NIS
TAN
GA
MB
IAP
OLA
ND
UG
AN
DA
ZIM
BA
BW
EIR
ELA
ND
ZA
MB
IAC
AM
ER
OO
NC
ON
GO
ET
HIO
PIA
IND
ON
ES
IAM
ALA
WI
MA
UR
ITIU
SR
WA
ND
AS
RI L
AN
KA
BO
TS
WA
NA
BR
UN
EI D
AR
US
SA
LAM
BU
RU
ND
IE
RIT
RE
AF
IJI
FR
AN
CE
GH
AN
AH
ON
G K
ON
GIR
AQ
ITA
LYJA
MA
ICA
KO
RE
A, R
EP
UB
LIC
OF
LIB
YA
LIT
HU
AN
IAM
ALA
YS
IAM
YA
NM
AR
PO
RT
UG
AL
PU
ER
TO
RIC
OR
US
SIA
N F
ED
ER
AT
ION
SA
INT
HE
LEN
AS
AU
DI A
RA
BIA
SIN
GA
PO
RE
SU
DA
NT
HA
ILA
ND
TU
RK
EY
UN
ITE
D S
TAT
ES
VIE
T N
AM
UN
KN
OW
N
Country of birth for all tuberculosis pa7ents in Oxfordshire 2007-‐2012
> >50/100000 <50/100000
Incidence
25/03/2014
13
384 pa7ents 2007-‐2012 Low incidence country of birth High incidence country of birth
Born%in%low%incidence%country%Total%pa2ents:%131%Pa2ents%in%a%WGS%cluster:%24%(18%)%
Born%in%high%incidence%country%Total%pa2ents:%254%Pa2ents%in%a%WGS%cluster:%17%(7%)%
Pulmonary%smear%posi2ve/culture%posi2ve%(sequenced)%
Pulmonary%smear%nega2ve/culture%posi2ve%(sequenced)%
ExtraKpulmonary%disease%(sequenced)%
Pulmonary/extraKpulmonary%disease,%culture%nega2ve%(not%sequenced)%
Figure%5%
Pulmonary/extraKpulmonary%disease,%culture%posi2ve%(not%sequenced)%
Born%in%low%incidence%country%Total%pa2ents:%131%Pa2ents%in%a%WGS%cluster:%24%(18%)%
Born%in%high%incidence%country%Total%pa2ents:%254%Pa2ents%in%a%WGS%cluster:%17%(7%)%
Pulmonary%smear%posi2ve/culture%posi2ve%(sequenced)%
Pulmonary%smear%nega2ve/culture%posi2ve%(sequenced)%
ExtraKpulmonary%disease%(sequenced)%
Pulmonary/extraKpulmonary%disease,%culture%nega2ve%(not%sequenced)%
Figure%5%
Pulmonary/extraKpulmonary%disease,%culture%posi2ve%(not%sequenced)%
125 pa7ents 255 pa7ents
( )
Born%in%low%incidence%country%Total%pa2ents:%131%Pa2ents%in%a%WGS%cluster:%24%(18%)%
Born%in%high%incidence%country%Total%pa2ents:%254%Pa2ents%in%a%WGS%cluster:%17%(7%)%
Pulmonary%smear%posi2ve/culture%posi2ve%(sequenced)%
Pulmonary%smear%nega2ve/culture%posi2ve%(sequenced)%
ExtraKpulmonary%disease%(sequenced)%
Pulmonary/extraKpulmonary%disease,%culture%nega2ve%(not%sequenced)%
Figure%5%
Pulmonary/extraKpulmonary%disease,%culture%posi2ve%(not%sequenced)%
Born%in%low%incidence%country%Total%pa2ents:%131%Pa2ents%in%a%WGS%cluster:%24%(18%)%
Born%in%high%incidence%country%Total%pa2ents:%254%Pa2ents%in%a%WGS%cluster:%17%(7%)%
Pulmonary%smear%posi2ve/culture%posi2ve%(sequenced)%
Pulmonary%smear%nega2ve/culture%posi2ve%(sequenced)%
ExtraKpulmonary%disease%(sequenced)%
Pulmonary/extraKpulmonary%disease,%culture%nega2ve%(not%sequenced)%
Figure%5%
Pulmonary/extraKpulmonary%disease,%culture%posi2ve%(not%sequenced)%
Low incidence country of birth High incidence country of birth 125 pa7ents 255 pa7ents
24 (18%) WGS clustered 17 (7%) epi clustered
( )
25/03/2014
14
Contact investigations for outbreaks of Mycobacterium tuberculosis:
advances through whole genome sequencing
T. M. Walker1, P. Monk2, E. Grace Smith3 and T. E. A. Peto1,4
1) Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, 2) East Midlands South Health Protection Unit, Leicester, 3) West
Midlands Public Health Laboratory, Health Protection Agency, Heart of England NHS Foundation Trust, Birmingham and 4) Oxford National Institute of Health
Research Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
Abstract
The control of tuberculosis depends on the identification and treatment of infectious patients and their contacts, who are currently identified
through a combined approach of genotyping and epidemiological investigation. However, epidemiological data are often challenging to obtain,
and genotyping data are difficult to interpret without them. Whole genome sequencing (WGS) technology is increasingly affordable, and
offers the prospect of identifying plausible transmission events between patients without prior recourse to epidemiological data. We discuss
the current approaches to tuberculosis control, and how WGS might advance public health efforts in the future.
Keywords: Contact investigation, outbreak, tuberculosis, whole genome sequencing
Clin Microbiol Infect
Corresponding author: T. M. Walker, Nuffield Department of
Medicine, University of Oxford, John Radcliffe Hospital, Headley Way,
Headington, Oxford, OX3 9DU, UK
E-mail: [email protected]
Introduction
The decline in tuberculosis incidence and mortality in western
Europe since the mid-18th century pre-dates the discovery of
the tubercle bacillus in 1882 and the development of drug
treatments in the 1940s. The reasons for this decline are
disputed, but hypotheses range from improvements in living
standards to the isolation of ‘consumptives’ in Poor Law
infirmaries and sanatoria. By 1990, this trend had been
reversed [1].
Historical trends in Africa, Asia and South America are less
well characterized, but historical and phylogeographical data
are consistent with the epidemics on these continents dating
back to the late 19th century, after the disease was probably
(re)-introduced by European colonizers [2,3]. Although this is
relatively late into the colonial period, in India the timing
coincides with a surge in British troop numbers after the 1857
mutiny, and the building of the railways that provided efficient
channels of transmission for disease [4]. The global burden of
disease is now felt most acutely on these continents, where
many of the world’s 2 billion people infected with latent or
active tuberculosis can be found [5].
Today, tuberculosis remains a disease of poverty in high-
income and low/middle-income countries alike. Without major
breakthroughs among experimental vaccines [6], available
control measures include contact tracing, active case-finding,
prophylaxis, and treatment. In high-income countries, contact
investigations have benefited from advances in genotyping
techniques over the past two decades. The arrival of rapid-
turn-around whole genome sequencing (WGS) technology has
the potential to guide public health teams in all settings with
unprecedented precision.
Epidemiology
Observations that patients with pulmonary tuberculosis often
do not lead to any secondary cases fuelled debate in the 19th
century about whether the disease was communicable at
all [7]. Although this issue was definitively settled by
Koch’s discovery, how a disease with a predominance of
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases
REVIEW 10.1111/1469-0691.12183
a.#
c.#
b.#
d.# e.#
Inferring direc7on of transmission
Contact investigations for outbreaks of Mycobacterium tuberculosis:
advances through whole genome sequencing
T. M. Walker1, P. Monk2, E. Grace Smith3 and T. E. A. Peto1,4
1) Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, 2) East Midlands South Health Protection Unit, Leicester, 3) West
Midlands Public Health Laboratory, Health Protection Agency, Heart of England NHS Foundation Trust, Birmingham and 4) Oxford National Institute of Health
Research Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
Abstract
The control of tuberculosis depends on the identification and treatment of infectious patients and their contacts, who are currently identified
through a combined approach of genotyping and epidemiological investigation. However, epidemiological data are often challenging to obtain,
and genotyping data are difficult to interpret without them. Whole genome sequencing (WGS) technology is increasingly affordable, and
offers the prospect of identifying plausible transmission events between patients without prior recourse to epidemiological data. We discuss
the current approaches to tuberculosis control, and how WGS might advance public health efforts in the future.
Keywords: Contact investigation, outbreak, tuberculosis, whole genome sequencing
Clin Microbiol Infect
Corresponding author: T. M. Walker, Nuffield Department of
Medicine, University of Oxford, John Radcliffe Hospital, Headley Way,
Headington, Oxford, OX3 9DU, UK
E-mail: [email protected]
Introduction
The decline in tuberculosis incidence and mortality in western
Europe since the mid-18th century pre-dates the discovery of
the tubercle bacillus in 1882 and the development of drug
treatments in the 1940s. The reasons for this decline are
disputed, but hypotheses range from improvements in living
standards to the isolation of ‘consumptives’ in Poor Law
infirmaries and sanatoria. By 1990, this trend had been
reversed [1].
Historical trends in Africa, Asia and South America are less
well characterized, but historical and phylogeographical data
are consistent with the epidemics on these continents dating
back to the late 19th century, after the disease was probably
(re)-introduced by European colonizers [2,3]. Although this is
relatively late into the colonial period, in India the timing
coincides with a surge in British troop numbers after the 1857
mutiny, and the building of the railways that provided efficient
channels of transmission for disease [4]. The global burden of
disease is now felt most acutely on these continents, where
many of the world’s 2 billion people infected with latent or
active tuberculosis can be found [5].
Today, tuberculosis remains a disease of poverty in high-
income and low/middle-income countries alike. Without major
breakthroughs among experimental vaccines [6], available
control measures include contact tracing, active case-finding,
prophylaxis, and treatment. In high-income countries, contact
investigations have benefited from advances in genotyping
techniques over the past two decades. The arrival of rapid-
turn-around whole genome sequencing (WGS) technology has
the potential to guide public health teams in all settings with
unprecedented precision.
Epidemiology
Observations that patients with pulmonary tuberculosis often
do not lead to any secondary cases fuelled debate in the 19th
century about whether the disease was communicable at
all [7]. Although this issue was definitively settled by
Koch’s discovery, how a disease with a predominance of
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases
REVIEW 10.1111/1469-0691.12183
Contact investigations for outbreaks of Mycobacterium tuberculosis:
advances through whole genome sequencing
T. M. Walker1, P. Monk2, E. Grace Smith3 and T. E. A. Peto1,4
1) Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, 2) East Midlands South Health Protection Unit, Leicester, 3) West
Midlands Public Health Laboratory, Health Protection Agency, Heart of England NHS Foundation Trust, Birmingham and 4) Oxford National Institute of Health
Research Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
Abstract
The control of tuberculosis depends on the identification and treatment of infectious patients and their contacts, who are currently identified
through a combined approach of genotyping and epidemiological investigation. However, epidemiological data are often challenging to obtain,
and genotyping data are difficult to interpret without them. Whole genome sequencing (WGS) technology is increasingly affordable, and
offers the prospect of identifying plausible transmission events between patients without prior recourse to epidemiological data. We discuss
the current approaches to tuberculosis control, and how WGS might advance public health efforts in the future.
Keywords: Contact investigation, outbreak, tuberculosis, whole genome sequencing
Clin Microbiol Infect
Corresponding author: T. M. Walker, Nuffield Department of
Medicine, University of Oxford, John Radcliffe Hospital, Headley Way,
Headington, Oxford, OX3 9DU, UK
E-mail: [email protected]
Introduction
The decline in tuberculosis incidence and mortality in western
Europe since the mid-18th century pre-dates the discovery of
the tubercle bacillus in 1882 and the development of drug
treatments in the 1940s. The reasons for this decline are
disputed, but hypotheses range from improvements in living
standards to the isolation of ‘consumptives’ in Poor Law
infirmaries and sanatoria. By 1990, this trend had been
reversed [1].
Historical trends in Africa, Asia and South America are less
well characterized, but historical and phylogeographical data
are consistent with the epidemics on these continents dating
back to the late 19th century, after the disease was probably
(re)-introduced by European colonizers [2,3]. Although this is
relatively late into the colonial period, in India the timing
coincides with a surge in British troop numbers after the 1857
mutiny, and the building of the railways that provided efficient
channels of transmission for disease [4]. The global burden of
disease is now felt most acutely on these continents, where
many of the world’s 2 billion people infected with latent or
active tuberculosis can be found [5].
Today, tuberculosis remains a disease of poverty in high-
income and low/middle-income countries alike. Without major
breakthroughs among experimental vaccines [6], available
control measures include contact tracing, active case-finding,
prophylaxis, and treatment. In high-income countries, contact
investigations have benefited from advances in genotyping
techniques over the past two decades. The arrival of rapid-
turn-around whole genome sequencing (WGS) technology has
the potential to guide public health teams in all settings with
unprecedented precision.
Epidemiology
Observations that patients with pulmonary tuberculosis often
do not lead to any secondary cases fuelled debate in the 19th
century about whether the disease was communicable at
all [7]. Although this issue was definitively settled by
Koch’s discovery, how a disease with a predominance of
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases
REVIEW 10.1111/1469-0691.12183
>C00005274 A A A C C C C A G G G G G G G T T T T>C00005481 A A G C T C C C G G A G G G G T T T T>C00005497 C A G G C C C C G G G A G G G T T T T>C00005510 A A A C C C C C G G G G G G T T C T T>C00005523 A A A C C C C C T T G G G G G T T C T>C00005526 A A A C C T C C G G G G G C G T T T T>C00007268 A G A C C C C C G G G G A G G C T T G>C00007282 A A A C C C T C G G G G G G G T T T T>C00007284 A A A C C C C C G G G G G G G T T T T
Inferring direc7on of transmission
25/03/2014
15
Articles
6 www.thelancet.com/infection Published online November 15, 2012 http://dx.doi.org/10.1016/S1473-3099(12)70277-3
epidemiologically linked (table). However, in the remaining six clusters, including one associated with an African immigrant community (cluster ten), only 25 (24%) of 103 patients could be epidemiologically linked (table).
None of 69 epidemiologically linked and two (15%) of 13 possibly epidemiology linked patients were separated by more than fi ve SNPs (seven and 12 SNPs respectively); conversely, 13 (17%) of 75 epidemiologically un linked patients were separated by more than fi ve SNPs and seven (9%) by more than 12 SNPs (three-way comparison exact p<0·0001; table). However, 22 potential transmissions of the 69 known to be epidemiologically linked featured in both household and community outbreaks. Excluding
those, the number of epidemiologically linked patients diff ering by fi ve SNPs or fewer was 47 (p=0·003).
The ability to identify cryptic outbreaks was most evident in cluster four, in which fi ve SNPs or fewer separated 38 individuals with a background of substance misuse for whom contact tracing had been diffi cult (table). The ability to rule out transmission was par ticularly evident in cluster ten, in which more than 30 SNPs separated fi ve individuals from a recent immigrant community and one British-born individual from the next nearest patient. In this cluster, isolates from ten patients from two cities 45 miles apart, with no known epidemiological links, could be genetically linked by fi ve or fewer SNPs.
0,1,1,1,1,1,21
0,7,7,7,8,8
7
7
7
4.
32
5
2
0
,
2,2,3,3,5,6,7
0,5,6,6,6,6,85
56
2,5
22,3,3,3,4,4
6
2
5
3
32,4,6
5,6
3,4
5
4 3
4,4,4,4,5
7 3
12.
11
1
4
7
7
0
4
9..
.
..
. .
..
.
8,9,9,9,9,11,12,1210
6
1110
2,9.
0,1,2,4,4
..
9,9,10,11
10
7 7
0 .4,5
5,6
9
5
2
93
.
.
.
.
...
..
..
0
. 0,0,0,0
0.
..
4
6
7
. ..
4
,
8,8
6
0*
,, 5
8
9
5,7
8,9
4
..........
....
....
..
..
..
..
..
..
....
....
....
..
....
..
..
..
..
..
..
..
..
6*
89
..
..
..
1 0
0
3.
50
. . .. .
..
.
7
7,8,8,8
7
8
7
7
0,6
6,,
6
..
7,
7.
3
8,8,8
5
7
7
,,
7
34
18
15
16
76
19
14
18
20
14
Cluster 1 Cluster 2 Cluster 3 Cluster 4
Cluster 5
Cluster 8
Cluster 7
Cluster 6
Cluster 9
Cluster 11
Cluster 10
Figure 4: Genetic distances within 11 community clustersGenetic distances estimated with maximum likelihood. Each blue circle represents a node of people who were infected with isolates separated by no SNPs. Each number within a circle is one patient, the number indicates at which year during the outbreak they were diagnosed (the fi rst infected is represented by 0). For patients with several isolates, the closest in SNPs to the next patient is included. Black circles are added when patients within blue circles are separated by more than one SNP; one black circle represents a diff erence of one SNP. Dashed lines in clusters three and ten show larger SNP distances (not to scale), with numbers representing the SNP diff erence. Arrows indicate the next closest isolate in the sequenced collection. Cluster fi ve has three red nodes that were sequenced after the blue nodes; the existence of the central red node was suggested by the constellation of surrounding blue nodes. SNP=single nucleotide polymorphism. *Two isolates from one patient.
?
>C00005274 A A A C C C C A G G G G G G G T T T T>C00005481 A A G C T C C C G G A G G G G T T T T>C00005497 C A G G C C C C G G G A G G G T T T T>C00005510 A A A C C C C C G G G G G G T T C T T>C00005523 A A A C C C C C T T G G G G G T T C T>C00005526 A A A C C T C C G G G G G C G T T T T>C00007268 A G A C C C C C G G G G A G G C T T G>C00007282 A A A C C C T C G G G G G G G T T T T>C00007284 A A A C C C C C G G G G G G G T T T T
Inferring direc7on of transmission
Articles
6 www.thelancet.com/infection Published online November 15, 2012 http://dx.doi.org/10.1016/S1473-3099(12)70277-3
epidemiologically linked (table). However, in the remaining six clusters, including one associated with an African immigrant community (cluster ten), only 25 (24%) of 103 patients could be epidemiologically linked (table).
None of 69 epidemiologically linked and two (15%) of 13 possibly epidemiology linked patients were separated by more than fi ve SNPs (seven and 12 SNPs respectively); conversely, 13 (17%) of 75 epidemiologically un linked patients were separated by more than fi ve SNPs and seven (9%) by more than 12 SNPs (three-way comparison exact p<0·0001; table). However, 22 potential transmissions of the 69 known to be epidemiologically linked featured in both household and community outbreaks. Excluding
those, the number of epidemiologically linked patients diff ering by fi ve SNPs or fewer was 47 (p=0·003).
The ability to identify cryptic outbreaks was most evident in cluster four, in which fi ve SNPs or fewer separated 38 individuals with a background of substance misuse for whom contact tracing had been diffi cult (table). The ability to rule out transmission was par ticularly evident in cluster ten, in which more than 30 SNPs separated fi ve individuals from a recent immigrant community and one British-born individual from the next nearest patient. In this cluster, isolates from ten patients from two cities 45 miles apart, with no known epidemiological links, could be genetically linked by fi ve or fewer SNPs.
0,1,1,1,1,1,21
0,7,7,7,8,8
7
7
7
4.
32
5
2
0
,
2,2,3,3,5,6,7
0,5,6,6,6,6,85
56
2,5
22,3,3,3,4,4
6
2
5
3
32,4,6
5,6
3,4
5
4 3
4,4,4,4,5
7 3
12.
11
1
4
7
7
0
4
9..
.
..
. .
..
.
8,9,9,9,9,11,12,1210
6
1110
2,9.
0,1,2,4,4
..
9,9,10,11
10
7 7
0 .4,5
5,6
9
5
2
93
.
.
.
.
...
..
..
0
. 0,0,0,0
0.
..
4
6
7
. ..
4
,
8,8
6
0*
,, 5
8
9
5,7
8,9
4
..........
....
....
..
..
..
..
..
..
....
....
....
..
....
..
..
..
..
..
..
..
..
6*
89
..
..
..
1 0
0
3.
50
. . .. .
..
.
7
7,8,8,8
7
8
7
7
0,6
6,,
6
..
7,
7.
3
8,8,8
5
7
7
,,
7
34
18
15
16
76
19
14
18
20
14
Cluster 1 Cluster 2 Cluster 3 Cluster 4
Cluster 5
Cluster 8
Cluster 7
Cluster 6
Cluster 9
Cluster 11
Cluster 10
Figure 4: Genetic distances within 11 community clustersGenetic distances estimated with maximum likelihood. Each blue circle represents a node of people who were infected with isolates separated by no SNPs. Each number within a circle is one patient, the number indicates at which year during the outbreak they were diagnosed (the fi rst infected is represented by 0). For patients with several isolates, the closest in SNPs to the next patient is included. Black circles are added when patients within blue circles are separated by more than one SNP; one black circle represents a diff erence of one SNP. Dashed lines in clusters three and ten show larger SNP distances (not to scale), with numbers representing the SNP diff erence. Arrows indicate the next closest isolate in the sequenced collection. Cluster fi ve has three red nodes that were sequenced after the blue nodes; the existence of the central red node was suggested by the constellation of surrounding blue nodes. SNP=single nucleotide polymorphism. *Two isolates from one patient.
?
>C00005274 A A A C C C C A G G G G G G G T T T T>C00005481 A A G C T C C C G G A G G G G T T T T>C00005497 C A G G C C C C G G G A G G G T T T T>C00005510 A A A C C C C C G G G G G G T T C T T>C00005523 A A A C C C C C T T G G G G G T T C T>C00005526 A A A C C T C C G G G G G C G T T T T>C00007268 A G A C C C C C G G G G A G G C T T G>C00007282 A A A C C C T C G G G G G G G T T T T>C00007284 A A A C C C C C G G G G G G G T T T T
Inferring direc7on of transmission
25/03/2014
16
Articles
6 www.thelancet.com/infection Published online November 15, 2012 http://dx.doi.org/10.1016/S1473-3099(12)70277-3
epidemiologically linked (table). However, in the remaining six clusters, including one associated with an African immigrant community (cluster ten), only 25 (24%) of 103 patients could be epidemiologically linked (table).
None of 69 epidemiologically linked and two (15%) of 13 possibly epidemiology linked patients were separated by more than fi ve SNPs (seven and 12 SNPs respectively); conversely, 13 (17%) of 75 epidemiologically un linked patients were separated by more than fi ve SNPs and seven (9%) by more than 12 SNPs (three-way comparison exact p<0·0001; table). However, 22 potential transmissions of the 69 known to be epidemiologically linked featured in both household and community outbreaks. Excluding
those, the number of epidemiologically linked patients diff ering by fi ve SNPs or fewer was 47 (p=0·003).
The ability to identify cryptic outbreaks was most evident in cluster four, in which fi ve SNPs or fewer separated 38 individuals with a background of substance misuse for whom contact tracing had been diffi cult (table). The ability to rule out transmission was par ticularly evident in cluster ten, in which more than 30 SNPs separated fi ve individuals from a recent immigrant community and one British-born individual from the next nearest patient. In this cluster, isolates from ten patients from two cities 45 miles apart, with no known epidemiological links, could be genetically linked by fi ve or fewer SNPs.
0,1,1,1,1,1,21
0,7,7,7,8,8
7
7
7
4.
32
5
2
0
,
2,2,3,3,5,6,7
0,5,6,6,6,6,85
56
2,5
22,3,3,3,4,4
6
2
5
3
32,4,6
5,6
3,4
5
4 3
4,4,4,4,5
7 3
12.
11
1
4
7
7
0
4
9..
.
..
. .
..
.
8,9,9,9,9,11,12,1210
6
1110
2,9.
0,1,2,4,4
..
9,9,10,11
10
7 7
0 .4,5
5,6
9
5
2
93
.
.
.
.
...
..
..
0
. 0,0,0,0
0.
..
4
6
7
. ..
4
,
8,8
6
0*
,, 5
8
9
5,7
8,9
4
..........
....
....
..
..
..
..
..
..
....
....
....
..
....
..
..
..
..
..
..
..
..
6*
89
..
..
..
1 0
0
3.
50
. . .. .
..
.
7
7,8,8,8
7
8
7
7
0,6
6,,
6
..
7,
7.
3
8,8,8
5
7
7
,,
7
34
18
15
16
76
19
14
18
20
14
Cluster 1 Cluster 2 Cluster 3 Cluster 4
Cluster 5
Cluster 8
Cluster 7
Cluster 6
Cluster 9
Cluster 11
Cluster 10
Figure 4: Genetic distances within 11 community clustersGenetic distances estimated with maximum likelihood. Each blue circle represents a node of people who were infected with isolates separated by no SNPs. Each number within a circle is one patient, the number indicates at which year during the outbreak they were diagnosed (the fi rst infected is represented by 0). For patients with several isolates, the closest in SNPs to the next patient is included. Black circles are added when patients within blue circles are separated by more than one SNP; one black circle represents a diff erence of one SNP. Dashed lines in clusters three and ten show larger SNP distances (not to scale), with numbers representing the SNP diff erence. Arrows indicate the next closest isolate in the sequenced collection. Cluster fi ve has three red nodes that were sequenced after the blue nodes; the existence of the central red node was suggested by the constellation of surrounding blue nodes. SNP=single nucleotide polymorphism. *Two isolates from one patient.
?
>C00005274 A A A C C C C A G G G G G G G T T T T>C00005481 A A G C T C C C G G A G G G G T T T T>C00005497 C A G G C C C C G G G A G G G T T T T>C00005510 A A A C C C C C G G G G G G T T C T T>C00005523 A A A C C C C C T T G G G G G T T C T>C00005526 A A A C C T C C G G G G G C G T T T T>C00007268 A G A C C C C C G G G G A G G C T T G>C00007282 A A A C C C T C G G G G G G G T T T T>C00007284 A A A C C C C C G G G G G G G T T T T
Inferring direc7on of transmission
Articles
6 www.thelancet.com/infection Published online November 15, 2012 http://dx.doi.org/10.1016/S1473-3099(12)70277-3
epidemiologically linked (table). However, in the remaining six clusters, including one associated with an African immigrant community (cluster ten), only 25 (24%) of 103 patients could be epidemiologically linked (table).
None of 69 epidemiologically linked and two (15%) of 13 possibly epidemiology linked patients were separated by more than fi ve SNPs (seven and 12 SNPs respectively); conversely, 13 (17%) of 75 epidemiologically un linked patients were separated by more than fi ve SNPs and seven (9%) by more than 12 SNPs (three-way comparison exact p<0·0001; table). However, 22 potential transmissions of the 69 known to be epidemiologically linked featured in both household and community outbreaks. Excluding
those, the number of epidemiologically linked patients diff ering by fi ve SNPs or fewer was 47 (p=0·003).
The ability to identify cryptic outbreaks was most evident in cluster four, in which fi ve SNPs or fewer separated 38 individuals with a background of substance misuse for whom contact tracing had been diffi cult (table). The ability to rule out transmission was par ticularly evident in cluster ten, in which more than 30 SNPs separated fi ve individuals from a recent immigrant community and one British-born individual from the next nearest patient. In this cluster, isolates from ten patients from two cities 45 miles apart, with no known epidemiological links, could be genetically linked by fi ve or fewer SNPs.
0,1,1,1,1,1,21
0,7,7,7,8,8
7
7
7
4.
32
5
2
0
,
2,2,3,3,5,6,7
0,5,6,6,6,6,85
56
2,5
22,3,3,3,4,4
6
2
5
3
32,4,6
5,6
3,4
5
4 3
4,4,4,4,5
7 3
12.
11
1
4
7
7
0
4
9..
.
..
. .
..
.
8,9,9,9,9,11,12,1210
6
1110
2,9.
0,1,2,4,4
..
9,9,10,11
10
7 7
0 .4,5
5,6
9
5
2
93
.
.
.
.
...
..
..
0
. 0,0,0,0
0.
..
4
6
7
. ..
4
,
8,8
6
0*
,, 5
8
9
5,7
8,9
4
..........
....
....
..
..
..
..
..
..
....
....
....
..
....
..
..
..
..
..
..
..
..
6*
89
..
..
..
1 0
0
3.
50
. . .. .
..
.
7
7,8,8,8
7
8
7
7
0,6
6,,
6
..
7,
7.
3
8,8,8
5
7
7
,,
7
34
18
15
16
76
19
14
18
20
14
Cluster 1 Cluster 2 Cluster 3 Cluster 4
Cluster 5
Cluster 8
Cluster 7
Cluster 6
Cluster 9
Cluster 11
Cluster 10
Figure 4: Genetic distances within 11 community clustersGenetic distances estimated with maximum likelihood. Each blue circle represents a node of people who were infected with isolates separated by no SNPs. Each number within a circle is one patient, the number indicates at which year during the outbreak they were diagnosed (the fi rst infected is represented by 0). For patients with several isolates, the closest in SNPs to the next patient is included. Black circles are added when patients within blue circles are separated by more than one SNP; one black circle represents a diff erence of one SNP. Dashed lines in clusters three and ten show larger SNP distances (not to scale), with numbers representing the SNP diff erence. Arrows indicate the next closest isolate in the sequenced collection. Cluster fi ve has three red nodes that were sequenced after the blue nodes; the existence of the central red node was suggested by the constellation of surrounding blue nodes. SNP=single nucleotide polymorphism. *Two isolates from one patient.
25/03/2014
17
Is it worth it?
Isoniazid Rifampicin Ethambutol Pyrazinamide Streptomycin Moxifloxacin Amikacin
WGS (2013) MulitDrug Resistant katG_S315T rpoB_S450L embB_M306V rpsL_K43R rrs_A1401G
Sample sequenced in one UK site - November 2013 Genetic code suggested resistance to five drugs
Is it worth it?
Isoniazid Rifampicin Ethambutol Pyrazinamide Streptomycin Moxifloxacin Amikacin
WGS (2013) MulitDrug Resistant katG_S315T rpoB_S450L embB_M306V rpsL_K43R rrs_A1401G
Sample sequenced in one UK site - November 2013 Genetic code suggested resistance to five drugs
Within 7 SNPs (mutations) of a sample from other end of the country
25/03/2014
18
Is it worth it?
Isoniazid Rifampicin Ethambutol Pyrazinamide Streptomycin Moxifloxacin Amikacin
WGS (2013) MulitDrug Resistant katG_S315T rpoB_S450L embB_M306V rpsL_K43R rrs_A1401G
Sample sequenced in one UK site - November 2013 Genetic code suggested resistance to five drugs
Reference lab (2010) XD Resistant R R R R R R
Within 7 SNPs (mutations) of a sample from other end of the country
Is it worth it?
Isoniazid Rifampicin Ethambutol Pyrazinamide Streptomycin Moxifloxacin Amikacin
WGS (2013) MulitDrug Resistant katG_S315T rpoB_S450L embB_M306V rpsL_K43R rrs_A1401G
Sample sequenced in one UK site - November 2013 Genetic code suggested resistance to five drugs
Reference lab (2010) XD Resistant R R R R R R
Within 7 SNPs (mutations) of a sample from other end of the country
Fluoroquinolone resistance muta/on Reference 2010 variant gyrA_A90V GCG GTG
25/03/2014
19
“Return of the plague” – BBC4 / iplayer
Oxford: Derrick Crook Tim Peto Sarah Walker Helen Barker Tonya Vo7nseva Louise Pankhurst Chris Conlon Carlos Del Ojo Adam Giess Tanya Golubchik Ka7e Jeffery Ian Bowler Marcus Morgan Lynn Parker Karen Payne Sheila Churchill Noel McCarthy Luisa Saldana Sarah Lamble Leeds Mark Wilcox Deborah Gascoyne-‐Binzi Brighton John Paul Kevin Cole
Birmingham: Grace Smith Li Xu Tonya Collins East Midlands South: Philip Monk TB reference labs: Francis Drobniewski Agnieszka Broda John Magee Anne Barres Ian Laurenson Colindale: Ibrahim Abubakar Lucy Thomas Laura Anderson Maeve Lalore Jennifer Davidson
Acknowledgements